Last $476.32 MXN
Change Today -0.74 / -0.16%
Volume 1.4K
PFE* On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 12:40 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by PFIZER INC (PFE*) in the last 6 months

Announced 01/5/15
Redvax GmbH
Merger/Acquisition

Pfizer Inc. (NYSE:PFE) acquired a controlling stake in Redvax GmbH from Redbiotec AG on January 5, 2015.


PFE*'s price was unchanged after the transaction was announced on 01/5/15.
Investor / Buyer
Pfizer Inc.
Creditor / Lender
Redbiotec AG
 
Announced 12/15/14
570.00M for Opko Health, Inc., Worldwide Licenses Of hGH-CTP
Merger/Acquisition

Pfizer Inc. (NYSE:PFE) entered into an agreement to acquire worldwide licenses of hGH-CTP from Opko Health, Inc. (NYSE:OPK) for $570 million on December 13, 2014. Under the terms of the agreement, Opko Health will receive an upfront payment of $295 million and is eligible to receive up to an additional $275 million upon the achievement of certain regulatory milestones. Pfizer will receive the exclusive license to commercialize hGH-CTP worldwide. The transaction is subject ...
Read More


PFE*'s price was unchanged after the transaction was announced on 12/15/14.
Investor / Buyer
Pfizer Inc.
Creditor / Lender
Opko Health, Inc.
 
Announced 12/8/14
iTeos Therapeutics SA
Private Placement

iTeos Therapeutics SA announced that it will receive equity funding from Pfizer Inc. on December 8, 2014.


PFE*'s price was unchanged after the transaction was announced on 12/8/14.
Investor / Buyer
Pfizer Inc.
 
Announced 10/23/14
11.00B for Pfizer Inc.
Buyback

Pfizer Inc. (NYSE:PFE) announces a share repurchase program. Under the program, the company will repurchase up to $11 billion worth of its shares. The plan will be utilized over time. The Board of Directors of Pfizer Inc. has authorized a buyback plan on October 23, 2014. On October 23, 2014, the company initiated a Market Repurchase.


PFE*'s price was unchanged after the transaction was announced on 10/23/14.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE*:MM $476.32 MXN -0.74

PFE* Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €128.11 EUR -1.40
Gilead Sciences Inc $106.09 USD -1.02
Johnson & Johnson $102.63 USD +0.37
Novartis AG SFr.88.85 CHF +1.85
Procter & Gamble Co/The $86.58 USD -3.00
View Industry Companies
 

Industry Analysis

PFE*

Industry Average

Valuation PFE* Industry Range
Price/Earnings 20.3x
Price/Sales 4.1x
Price/Book 2.7x
Price/Cash Flow 14.1x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.